{"Title": "Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse", "Year": 2017, "Source": "Br. J. Haematol.", "Volume": "177", "Issue": 3, "Art.No": null, "PageStart": 495, "PageEnd": 497, "CitedBy": 0, "DOI": "10.1111/bjh.14086", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84963831767&origin=inward", "Abstract": null, "AuthorKeywords": ["bortezomib", "myeloma", "myeloma therapy", "relapse"], "IndexKeywords": ["Antineoplastic Agents", "Bortezomib", "Humans", "Multiple Myeloma", "Recurrence", "Retreatment", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84963831767", "SubjectAreas": [["Hematology", "MEDI", "2720"]], "AuthorData": {"6504065568": {"Name": "Reyal Y.", "AuthorID": "6504065568", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Haematology, UCL Cancer Institute, University College London"}, "8645053700": {"Name": "Popat R.", "AuthorID": "8645053700", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Haematology, UCL Cancer Institute, University College London"}, "55447837800": {"Name": "Cheesman S.", "AuthorID": "55447837800", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals NHS Trust"}, "57188860649": {"Name": "Rismani A.", "AuthorID": "57188860649", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals NHS Trust"}, "6602503855": {"Name": "D'Sa S.", "AuthorID": "6602503855", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals NHS Trust"}, "22136212200": {"Name": "Rabin N.", "AuthorID": "22136212200", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals NHS Trust"}, "7102064249": {"Name": "Yong K.", "AuthorID": "7102064249", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Haematology, UCL Cancer Institute, University College London"}}}